Driving Innovation
for Life Sciences in Europe

About EUCOPE

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ biopharmaceutical companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. At EUCOPE, we provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures.

Read more…

Upcoming Events

5
Dec

5. December 2022 to 8. December 2022 — Register Here

Cell & Gene Therapy Manufacturing & Commercialization Europe

Europe’s cell and gene therapy congress for groundbreaking manufacturing, commercialization & supply chain strategies. Hear from the world-renowned leaders who share the latest analytical techniques & vector technologies to revolutionize your cell, gene & gene-edited ex vivo cell therapy programs. EUCOPE’s Alexander Natz will speak… read more

6
Dec

6. December 2022 — Register Here

Cure Signature Series: Song of the Cell

**This is an event from a EUCOPE Member Join us at Cure® for the first installment of our Signature Initiative, where we will be joined by Pulitzer Prize-winning and #1 New York Times bestselling author, Siddhartha Mukherjee to discuss his newest book release, The Song… read more

7
Dec

7. December 2022 — Register Here

Ecosystème des Tests de Diagnostics Génomiques en France : présentation de la perspective française

**This event takes place entirely in French and is co-organised by EUCOPE and Alira Health. Le 7 décembre, nous rencontrerons les principaux experts français afin de mettre en avant les avantages des solutions de diagnostic avancé et aborder les principaux challenges qu’ils rencontrent pour accéder… read more

8
Dec

8. December 2022 — Register Here

European Health Summit

The theme of this year’s European Health Summit is “Maintaining Europe’s Momentum: Driving Resilience Forward.” The European Health Summit 2022 is an exclusive invitation-only event. Due to security reasons, on-the-spot registration will not be possible. Only registered participants will be able to enter the conference space…. read more

15
Feb

15. February 2023 — Register Here

Europe Rare Disease Summit 2023

The European Rare Disease Summit will bring together local and European government authorities, members of the European Commission and the European Parliament, large public and private hospital groups, research centres, pharmaceutical and patient associations, regulatory agencies and scientific societies and healthcare professionals from across Europe…. read more

News & Updates

EUCOPE Member Spotlight: Q&A with Ferrer

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In October, we spoke with Óscar Perez, Chief Officer, Marketing, Pricing & Market Access and Business Development at Ferrer Internacional…. read more

Three new members join EUCOPE before the end of 2022

The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of three (3) new members at its quarterly Members Meeting on October 19th 2022 following Board approval. The new members joining EUCOPE network are: Genesis Pharma, Mirati Therapeutics and Moderna. During the announcement, EUCOPE’s Secretary… read more

Remap Consulting survey on the new EU HTA regulation

Remap Consulting has launched a short survey to gather feedback from biotech, pharmaceutical and medical device companies on the new EU HTA regulation, and how prepared they are for it. Remap is eager to get feedback from small and mid-sized companies as part of the… read more

Expert Conference on Rare Diseases: Towards a New European Policy Framework: “Building the future together for rare diseases”

On the 25th and 26th of October 2022, experts on rare diseases joined the Expert Conference on Rare Diseases in Prague organised by the Czech Presidency of the EU together with EURORDIS. The event built on a series of technical and ministerial gatherings on proposals… read more

EUCOPE Member Spotlight: Q&A with Grifols

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In October, we spoke with Cesar Rubio, Associate Director, Government and Public Affairs, Grifols. César Rubio is Associate Director,… read more

EUCOPE Member Spotlight: Q&A with PTC Therapeutics

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In October, we spoke with Adrian Haigh, Senior Vice President and Head of International at PTC Therapeutics, Inc. Adrian… read more

EUCOPE/EFPIA Joint Statement: Concerns over the implementation of the EU HTA Regulation

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and European Federation of Pharmaceutical Industries and Associations (EFPIA) have concerns on the current direction of the implementation of the EU HTA Regulation. We are firmly convinced that the input from patient organizations, healthcare professionals, industry and HTA experts and… read more

Event Recap – TRANSFORM Alliance Charter Launch (13 October 2022)

EUCOPE discusses solutions across the R&D lifecycle to build a European system fit for transformative therapies On the 13th of October 2022, the European Alliance for Transformative Therapies (TRANSFORM) came together with the MEP Interest Group to launch an MEP Charter in the European Parliament…. read more

Event Recap – Alexion’s Rare Disease Policies (13 October 2022)

On 13 October 2022, Alexion held a high-level conference, as part of the “Rare Conversations” event series, on rare disease policies at the Bibliotheque Solvay in Brussels. Alexion’s recent conference in Brussels, Rare Disease Policies 2022, was an insightful look into the possibilities for the… read more

🎙️Sounds of Science Episode 9 on ATMPs

Sounds of Science Podcast – Episode 9 Advanced Therapy Medicinal Products (ATMPs): How they will be impacted by the General Pharmaceutical Legislation On our latest episode, we explore the topic of Advanced Therapy Medical Products, or ATMPs. This covers a wide range of therapies, but… read more

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership